or Connect
HotStockMarket › Forums › HSM Stock Forum › Trade Journals & Stock Tips › The Alert Competition Room - rules on first post
New Posts  All Forums:Forum Nav:

The Alert Competition Room - rules on first post - Page 7

post #121 of 137
Thread Starter 
Haven't posted in a while

my scan
ILNS .0035
stock-chart-str.aspx?id=ilns&ca=24062939
post #122 of 137
Thread Starter 
also just a scan MRNJ .003ish

stock-chart-str.aspx?id=mrnj&ca=24062939
post #123 of 137
Thread Starter 
No more scans unless someone sends me $1200. Sorry.
post #124 of 137
Thread Starter 

Anyone know how to post sub-penny charts now?

 

Like I said I can't afford my screener and the markets are rough now but I think their might be some interest in

 

ARSC .0001 and UNDT .0006  just based on mania.

 

Maybe MNGA .135 if they are for real

 

and MDGC's .0049 chart looked good to me

post #125 of 137
Thread Starter 

UNDT hit .0026 and might be ready for another wave up now at .0016

 

Can someone tell me how to post sub penny charts now?- otherwise I will be completely done giving alerts I suppose- no fun without the charts for evidence.

post #126 of 137
Thread Starter 

BBDA .016/9 are they legit?

 

especially if they get past .03  but out if it gets under .01 I would think.

post #127 of 137
Thread Starter 

 

started poppiing .0112 now

 

MultiCell Technologies, Inc. (OTC Bulletin Board: MCET) is pleased to announce the issuance of U.S. patent 7,935,528 by the United States Patent and Trademark Office (USPTO) relating to the isolation and use of human liver stem cells to treat liver disease. Under the terms of its license agreement with Rhode Island Hospital, MultiCell Technologies is the worldwide exclusive licensee of U.S. patent 7,935,528.

The patent describes methods to isolate and use human liver stem cells to treat degenerative liver diseases, or inherited deficiencies of liver function. Patients who suffer from severe, irreversible liver disease for which other medical and surgical treatments have failed are often candidates for a liver transplant. Liver stem cells which differentiate into functional mature hepatocytes could help to reconstitute a diseased liver, and may be an alternative approach to whole organ transplants for certain liver diseases.

"We are pleased the USPTO has agreed that our liver stem cells are indeed novel and may lead to important therapeutic applications," said W. Gerald Newmin, Chairman and Chief Executive Officer. "Our efforts to better understand liver stem cell biology, and the role these cells play in chronic liver disease and primary hepatocellular carcinoma, is a major focus of the Company," Mr. Newmin stated.

About MultiCell Technologies, Inc.

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. For more information about MultiCell Technologies, please visit http://www.multicelltech.com.

post #128 of 137
Thread Starter 

http://www.marketwire.com/press-release/wanderport-completes-in-house-testing-pinksheets-wdrp-1523270.htm#

 

WDRP .05 ish now,

 

seems like there is a bit of work left to be done, but this could fly soon

post #129 of 137
Thread Starter 

http://www.google.com/finance?q=Rentech

 
 
Cautionary note. A Bloomberg New Energy Finance analyst predicted that “The real winners of this type of regulatory breakthrough will be technology companies involved in the production of aviation biofuels. The biotech-biofuels business models of Amyris Inc., Codexis Inc., Gevo Inc. and Solazyme Inc. are all making claims to these types of new markets.” Amyris and Gevo are not producing Bio-SPK fuels and are not directly impacted by the announcement – although Solazyme will receive a potential direct impact for its Bio-SPK-based Solajet fuel, which it is producing in large test quantities for the US Navy among other customers..
 

There is another fuel spec, approved some time ago, which relates to bio-based fuels produced using the Fischer-Tropsch process. Rentech is among the leading companies producing this fuel, which is already approved for use and was the subject of a 13-airline offtake agreement at LAX, announced last year. Rentech is also working with UOP for unionfining, unicracking and dewaxing technologies.

In addition, several companies are developing technologies that will produce jet fuels directly from fermentation, or from catalytic conversion processes. Companies pursuing this track include Cobalt Technologies, Gevo, Amyris, Joule Unlimited, and Virent. The latest guidance from Amyris suggests that they expect to see approval and commercial-scale production of those fuels by mid-decade.

 
RTK .88
 
If someone gets rich I'm starving!
 
BBDA now .0033, I would buy some now and if they hit .0001 if I had a lot of disposable income, but the timing is wrong I think.
post #130 of 137
Thread Starter 

Last public alert TAON .0016

 

Called PGIE, SAVW and BRAV this month, believe me or not- to bad I am broke.

 

RTK now .97

 

BBDA .01

post #131 of 137

TDEY $0.03 first post.  with A/H News; EMLL $0.0004 first post, with News this morning

post #132 of 137
Thread Starter 

Its not as much fun without charts, if anyone knows how to get updating charts please post how in this thread.

 

News alerts

 

 CVE:DYA 0.10

 

SZYM 12.99

post #133 of 137
Thread Starter 

SNEY over .008 looks good to me.

 

edit: SZYM 11.92 boo needs to get through $13

 

DYA .195 yay

post #134 of 137
Thread Starter 
post #135 of 137
Thread Starter 
post #136 of 137
Thread Starter 

http://www.hotstockmarket.com/quote

solar using graphene nanotech

MGLT .10

post #137 of 137
Thread Starter 
New Posts  All Forums:Forum Nav:
  Return Home
  Back to Forum: Trade Journals & Stock Tips
HotStockMarket › Forums › HSM Stock Forum › Trade Journals & Stock Tips › The Alert Competition Room - rules on first post